Literature DB >> 4252528

Clioquinol and neurological disease.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4252528      PMCID: PMC1796085     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  PROPHYLAXIS AND THERAPY OF AMEBIASIS AND SHIGELLOSIS WITH IODOCHLORHYDROXYQUIN.

Authors:  L M GHOLZ; W L ARONS
Journal:  Am J Trop Med Hyg       Date:  1964-05       Impact factor: 2.345

2.  Neurological disorders associated with adult coeliac disease.

Authors:  W T Cooke; W T Smith
Journal:  Brain       Date:  1966-12       Impact factor: 13.501

3.  Neurological syndrome associated with clioquinol.

Authors:  T Tsubaki; Y Honma; M Hoshi
Journal:  Lancet       Date:  1971-04-03       Impact factor: 79.321

4.  Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study.

Authors:  P M Fullerton; D J O'Sullivan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-12       Impact factor: 10.154

5.  Amaurosis after broxyquinoline.

Authors:  B Strandvik; R Zetterström
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

6.  [Possible neurotoxicity of oxyquinolines].

Authors:  H E Kaeser; R Wüthrich
Journal:  Dtsch Med Wochenschr       Date:  1970-08-14       Impact factor: 0.628

7.  Myeloneuropathy with abdominal disorders in Japan. A clinical study of 752 cases.

Authors:  I Sobue; K Ando; M Iida; T Takayanagi; Y Yamamura; Y Matsuoka
Journal:  Neurology       Date:  1971-02       Impact factor: 9.910

  7 in total
  2 in total

1.  Peripheral neuropathy in ageing rats fed clioquinol and a maize diet.

Authors:  E L Jones; C E Searle; W T Smith
Journal:  Acta Neuropathol       Date:  1973-05-16       Impact factor: 17.088

Review 2.  Pharmacotherapeutic targets in Alzheimer's disease.

Authors:  Yif'at Biran; Colin L Masters; Kevin J Barnham; Ashley I Bush; Paul A Adlard
Journal:  J Cell Mol Med       Date:  2008-11-18       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.